Evidence map›Paper›PMID 25426557›Full record

ArticleOncotarget2015

Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.

Takumi Shiraishi, James E Verdone, Jessie Huang, Ulf D Kahlert, James R Hernandez, Gonzalo Torga, Jelani C Zarif, Tamir Epstein, Robert Gatenby, Annemarie McCartney and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 1 synthesis or guideline pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. The Role of Glucose Metabolism inInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. The pyruvate branch point controls lymphoid cancer cell dissemination.bioRxiv : the preprint server for biology · 2026
    Article
  7. Monocytes are biological sensors of aging and frailty in humans.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Anoikis: To Die or Not to Die?International journal of molecular sciences · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Takumi ShiraishiDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
James E VerdoneDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Jessie HuangDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ulf D KahlertDepartment of Pathology, Division of Neuropathology, The Johns Hopkins Hospital, Baltimore, MD, USA.
James R HernandezDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Gonzalo TorgaDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Jelani C ZarifDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Tamir EpsteinDepartment of Integrative Mathematical Oncology and Department of Diagnostic Imaging, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Robert GatenbyDepartment of Integrative Mathematical Oncology and Department of Diagnostic Imaging, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Annemarie McCartneyThe Wilmer Eye Institute and Department of Biomedical Engineering, Baltimore, MD, USA.
Jennifer H ElisseeffThe Wilmer Eye Institute and Department of Biomedical Engineering, Baltimore, MD, USA.
Steven M MooneyDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Steven S AnDepartment of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA. Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. In Vivo Cellular and Molecular Imaging Center, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Kenneth J PientaDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. Department of Oncology, Johns Hopkins University, Baltimore, MD, USA. Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD, USA. Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins University · USMoffitt Cancer Center · USNational Eye Institute · USJohns Hopkins Hospital · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007309 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 1985 to 2019
$43.2M
Tumor microvesicle-mediated modulation of the bone microenvironmentP01CA093900 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J. · 2004 to 2024
$29.6M
Theranostic Imaging of Metastatic Prostate CancerP50CA103175 · NCI · JOHNS HOPKINS UNIVERSITY · PI BARKER, PETER B · 2003 to 2015
$17.9M
TRANS NETWORK PROJECTSU54CA143868 · NCI · JOHNS HOPKINS UNIVERSITY · PI SEARSON, PETER C · 2009 to 2013
$13.7M
Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Integrative Molecular Epidemiology WorkshopR25CA174664 · NCI · AMERICAN ASSOCIATION FOR CANCER RESEARCH · PI Shelley S Tworoger · 2013 to 2026
$2.8M
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer ProgressionU01CA143055 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J., ROWLEY, DAVID R · 2010 to 2014
$2.7M
Nrf2 as a critical determinant of smooth muscle functionR01HL107361 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI AN, STEVEN S · 2011 to 2015
$2.0M
Spatiotemporal Regulation of Chk1 in Cell Biology, Cancer Etiology and TherapyR01CA163214 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ZHANG, YOU-WEI · 2012 to 2016
$1.6M
Raman spectroscopy probes for assisting stereotactic breast biopsy needle placemeR43CA141868 · NCI · NEWTON LABORATORIES · PI FULGHUM, STEPHEN FREDERICK · 2009 to 2009
$100k
NCI NIH HHS 1P01CA093900NCI NIH HHS P01 CA093900NCI NIH HHS P50 CA103175NCI NIH HHS P50CA103175NCI NIH HHS R01 CA163214NCI NIH HHS R25 CA174664NCI NIH HHS R43 CA141868NCI NIH HHS U01 CA143055NCI NIH HHS U01CA143055NCI NIH HHS U54CA141868NCI NIH HHS U54 CA143868NCI NIH HHS U54CA163214NHLBI NIH HHS HL107361NHLBI NIH HHS R01 HL107361NIGMS NIH HHS T32 GM007309NIGMS NIH HHS T32 GM008752
6 · The paper itself

Abstract

The ability of a cancer cell to detach from the primary tumor and move to distant sites is fundamental to a lethal cancer phenotype. Metabolic transformations are associated with highly motile aggressive cellular phenotypes in tumor progression. Here, we report that cancer cell motility requires increased utilization of the glycolytic pathway. Mesenchymal cancer cells exhibited higher aerobic glycolysis compared to epithelial cancer cells while no significant change was observed in mitochondrial ATP production rate. Higher glycolysis was associated with increased rates of cytoskeletal remodeling, greater cell traction forces and faster cell migration, all of which were blocked by inhibition of glycolysis, but not by inhibition of mitochondrial ATP synthesis. Thus, our results demonstrate that cancer cell motility and cytoskeleton rearrangement is energetically dependent on aerobic glycolysis and not oxidative phosphorylation. Mitochondrial derived ATP is insufficient to compensate for inhibition of the glycolytic pathway with regard to cellular motility and CSK rearrangement, implying that localization of ATP derived from glycolytic enzymes near sites of active CSK rearrangement is more important for cell motility than total cellular ATP production rate. These results extend our understanding of cancer cell metabolism, potentially providing a target metabolic pathway associated with aggressive disease.

Indexed as

Cell MovementGlycolysisAdenosine TriphosphateAerobiosisBreast NeoplasmsCytoskeletonDNA, MitochondrialEpithelial CellsFemaleGene Expression Regulation, NeoplasticHumansMaleMesenchymal Stem CellsMicroscopy, Phase-ContrastMitochondriaNeoplastic Stem CellsAdenosine TriphosphateDNA, MitochondrialOxygen

Identifiers

PMID25426557
PMCPMC4381583
OpenAlexW1860424934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.